Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis

doi:10.3748/wjg.v18.i10.1048

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6287)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

629

HTML

5353

Figures (1-6)

188

Tables (1-1)

117

Sum=6287

Mar 14, 2012 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (97)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Mar 14, 2012; 18(10): 1048-1058
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1048

Full Size Figure Download Figure

Figure 6 Enzyme linked immunosorbent assay analysis for detecting interleukin-10 protein expression in peripheral blood after intravenous, intrahepatic and intraperitoneal mesenchymal stem cell injection. Values shown are mean ± SE, ^aP < 0.05. IL-10: Interleukin-10.

Citation: Zhao W, Li JJ, Cao DY, Li X, Zhang LY, He Y, Yue SQ, Wang DS, Dou KF. Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol 2012; 18(10): 1048-1058
URL: https://www.wjgnet.com/1007-9327/full/v18/i10/1048.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i10.1048